Gossamer Bio Ownership | Who Owns Gossamer Bio?
Gossamer Bio Ownership Summary
Gossamer Bio is owned by 8.19% institutional investors, 3.92% insiders, and 87.88% retail investors. Nea management company is the largest institutional shareholder, holding 7.96% of GOSS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.45% of its assets in Gossamer Bio shares.
GOSS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Gossamer Bio | 8.19% | 3.92% | 87.88% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nea management company | 18.09M | 7.96% | $47.58M |
| Octagon capital advisors lp | 17.05M | 7.50% | $44.84M |
| Blackrock funding, inc. /de | 13.85M | 6.09% | $36.42M |
| Vanguard group | 12.01M | 5.28% | $31.59M |
| Arch venture management | 8.06M | 3.54% | $21.19M |
| Samsara biocapital | 6.13M | 2.70% | $16.12M |
| Palo alto investors lp | 5.46M | 2.40% | $14.37M |
| Siren | 5.21M | 2.29% | $13.70M |
| 683 capital management | 5.06M | 2.23% | $13.31M |
| Acadian asset management | 5.01M | 2.21% | $13.18M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Octagon capital advisors lp | 17.05M | 6.80% | $44.84M |
| Arch venture management | 8.06M | 4.30% | $21.19M |
| Palo alto investors lp | 5.46M | 2.66% | $14.37M |
| Nea management company | 18.09M | 2.61% | $47.58M |
| Mb generational wealth | 1.41M | 2.36% | $3.72M |
| Samsara biocapital | 6.13M | 2.10% | $16.12M |
| Silverarc capital management | 4.78M | 1.69% | $12.57M |
| Opaleye management | 2.73M | 1.01% | $7.17M |
| Exome asset management | 451.70K | 0.72% | $1.19M |
| 683 capital management | 5.06M | 0.70% | $13.31M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | 3.81M | 0.29% | 3.81M |
| Ubs group | 2.77M | 0.00% | 2.46M |
| Blackrock funding, inc. /de | 13.85M | 0.00% | 1.70M |
| Mb generational wealth | 1.41M | 2.36% | 1.41M |
| State street | 3.88M | 0.00% | 1.40M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | - | - | -9.20M |
| Farallon capital management | - | - | -6.13M |
| Madison avenue partners, lp | - | - | -4.14M |
| Ci private wealth | 20.01K | 0.00% | -3.67M |
| Fmr | 4.09M | 0.00% | -3.23M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Perceptive advisors | 3.81M | 0.29% | 3.81M | $10.03M |
| Mb generational wealth | 1.41M | 2.36% | 1.41M | $3.72M |
| Tang capital management | 800.00K | 0.08% | 800.00K | $2.10M |
| Adage capital partners gp | 726.80K | 0.00% | 726.80K | $1.91M |
| Russell investments group | 685.05K | 0.00% | 685.05K | $1.80M |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -4.00 |
| Pfs partners | -50.00 |
| Northwestern mutual wealth management | -261.00 |
| Raymond james financial | -270.00 |
| Global retirement partners | -300.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 43 | -65.60% | 18,623,130 | -89.32% | 8 | 0.14% | 28 | -59.42% | 11 | -56.00% |
| Jun 30, 2025 | 132 | 4.76% | 176,036,505 | 3.57% | 77 | 1.38% | 71 | 12.70% | 28 | -6.67% |
| Mar 31, 2025 | 23 | -79.82% | 67,155,072 | -60.80% | 29 | 0.52% | 7 | -85.11% | 6 | -77.78% |
| Dec 31, 2024 | 108 | 0.93% | 166,819,185 | -4.61% | 73 | 1.23% | 46 | 4.55% | 24 | -11.11% |
| Sep 30, 2024 | 107 | 7.00% | 174,874,925 | -4.36% | 77 | 1.18% | 44 | 7.32% | 27 | -10.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 7.84M | 3.45% | - |
| Vanguard Total Stock Mkt Idx Inv | 6.80M | 2.99% | 33.18K |
| Fidelity Select Biotechnology | 5.45M | 2.40% | -2.13M |
| iShares Russell 2000 ETF | 4.65M | 2.04% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.04M | 0.90% | -932.41K |
| Fidelity Small Cap Index | 1.90M | 0.83% | 1.90M |
| iShares Russell 2000 Growth ETF | 1.69M | 0.74% | - |
| Fidelity Extended Market Index | 1.03M | 0.45% | -8.46K |
| Schwab US Small-Cap ETF™ | 929.69K | 0.41% | 2.38K |
| Vanguard Russell 2000 ETF | 908.06K | 0.40% | -58.84K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 19, 2025 | Milligan Sandra | - | Buy | $50.02K |
| Jun 24, 2024 | Aranda Richard | Chief Medical Officer | Sell | $1.26K |
| Jun 21, 2024 | Hasnain Faheem | President & CEO | Buy | $250.28K |
| Jun 18, 2024 | Giraudo Bryan | COO/CFO | Buy | $59.11K |
| Jun 17, 2024 | Smith Robert Paul JR | Chief Commercial Officer | Buy | $15.05K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | 1 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q2 | 3 | 1 |
GOSS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools